AstraZeneca said today it will create new R&D centers focused on drug development and artificial intelligence (AI) in Shanghai, as well as partner with state-run China International Capital Corporation Limited (CICC) to launch a potentially $1 billion fund whose investments will aim to advance innovation in China’s healthcare system.
Image: AstraZeneca’s China headquarters at Shanghai Zhangjiang Hi-Tech Park – https://www.genengnews.com
{iframe}https://www.genengnews.com/news/astrazeneca-to-create-1b-fund-rd-centers-in-china/?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=01&utm_campaign=GEN+Daily+News+Highlights_20191107&oly_enc_id=1673D8247356B7U{/iframe}